Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Synaptogenix Inc

SNPX
Current price
3.08 USD +0.16 USD (+5.48%)
Last closed 3.03 USD
ISIN US87167T2015
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 4 012 605 USD
Yield for 12 month -54.54 %
1Y
3Y
5Y
10Y
15Y
SNPX
21.11.2021 - 28.11.2021

Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company. It is conducting clinical and preclinical studies of its lead therapeutic candidate, Bryostatin-1, in Alzheimer's disease. Its preclinical studies have also demonstrated bryostatin's regenerative mechanisms of action for the rare disease Fragile X syndrome, and for other neurodegenerative disorders, such as multiple sclerosis, stroke, and traumatic brain injury. The U.S. Food and Drug Administration has granted Orphan Drug Designation to Synaptogenix for Bryostatin-1 as a treatment for Fragile X syndrome. The company was incorporated in 2012 and is headquartered in New York, New York. Address: 1185 Avenue of the Americas, New York, NY, United States, 10036

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

14 USD

P/E ratio

0.2882

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

+10 274 USD

Current Year

-6 347 USD

Last Year

-5 714 USD

Current Quarter

-1 317 USD

Last Quarter

-1 399 USD

Key Figures SNPX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -6 829 012 USD
Operating Margin TTM
PE Ratio 0.2882
Return On Assets TTM -13.82 %
PEG Ratio
Return On Equity TTM -7.5 %
Wall Street Target Price 14 USD
Revenue TTM
Book Value 14.99 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share 10.27 USD
Diluted Eps TTM 10.27 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics SNPX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History SNPX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:25
Payout Ratio
Last Split Date 05.04.2024
Dividend Date

Stock Valuation SNPX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 0.2882
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 1.2817
Price Book MRQ 0.2135

Financials SNPX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SNPX

For 52 weeks

2.72 USD 8.78 USD
50 Day MA 3.22 USD
Shares Short Prior Month 7 976
200 Day MA 4.19 USD
Short Ratio 0.86
Shares Short 17 564
Short Percent 1.31 %